๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of angiotensin II in nonalcoholic steatohepatitis

โœ Scribed by Matthew Morris, E.; Fletcher, Justin A.; Thyfault, John P.; Scott Rector, R.

Book ID
120557391
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
638 KB
Volume
378
Category
Article
ISSN
0303-7207

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Therapeutic efficacy of an angiotensin I
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
โœ Shiro Yokohama; Masashi Yoneda; Masakazu Haneda; Satoshi Okamoto; Mituyoshi Okad ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

The therapeutic efficacy of angiotensin II receptor antagonist, losartan, was studied in patients with nonalcoholic steatohepatitis (NASH). Seven patients with both NASH and hypertension were treated with losartan (50 mg/d) for 48 weeks. Treatment with losartan resulted in a significant decrease in

Targeting the renin-angiotensin system:
Targeting the renin-angiotensin system: Potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis
โœ Silvia Sookoian; Carlos J. Pirola ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 209 KB ๐Ÿ‘ 1 views

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong